Concepedia

Author

Alfons Segarra

Vall d'Hebron Hospital Universitari

Also Known As

A Coves Segarra, ALFONS SEGARRA, Alfons Segarra, Alfons Segarra1

44

Publications

2.2K

Citations

22

H-Index

39

Concepts

All Affiliations

Vall d'Hebron Hospital UniversitariHospital Universitario 12 De OctubreHospital Universitario Reina SofíaHospital Universitari Arnau de VilanovaHospital Universitari i Politècnic La Fe
AS

About

Alfons Segarra is an author at Vall d'Hebron Hospital Universitari specializing in medicine, immunology, and glomerular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

443

2

Immunology

5

5

433

3

Pathology

4

4

405

4

Nephrology

3

3

291

5

Emergency Medicine

1

1

10

Alfons Segarra

×

24

Publications

2.1K

Citations

20

H-Index

YearCitations

Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial

Lourdes Lozano, José L. Tovar, Gabriel Sampol,

Journal of Hypertension

2010

253

The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt,

Kidney International

2020

220

Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy

Mario Espinosa, Rosa Ortega, Marina Sánchez,

Clinical Journal of the American Society of Nephrology

2014

207

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen,

Kidney International

2022

205

Long-Term Outcomes of IgA Nephropathy Presenting with Minimal or No Proteinuria

Eduardo Gutiérrez, I. Zamora, José Ballarín,

Journal of the American Society of Nephrology

2012

175

Elevated factor H–related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy

Agustín Tortajada, Eduardo Gutiérrez, Elena Goicoechea de Jorge,

Kidney International

2017

114

Combined therapy of tacrolimus and corticosteroids in cyclosporin‐resistant or ‐dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow‐up†

Alfons Segarra, Josefa Vila, Leonor Pou,

Nephrology Dialysis Transplantation

2002

112

Circulating Levels of Plasminogen Activator Inhibitor Type-1, Tissue Plasminogen Activator, and Thrombomodulin in Hemodialysis Patients

Alfons Segarra, PILAR CHACOCombining Acute AccentN, CRISTINA MARTINEZ-EYARRE,

Journal of the American Society of Nephrology

2001

101

Antihistone and anti–double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus

Josefina Cortés-Hernández, Josep Ordi‐Ros, Moisés Labrador‐Horrillo,

The American Journal of Medicine

2004

96

Successful Treatment of Membranous Glomerulonephritis with Rituximab in Calcineurin Inhibitor-Dependent Patients

Alfons Segarra, Manuel Praga, Natàlia Ramos,

Clinical Journal of the American Society of Nephrology

2009

92

Page 1